Submissions for variant NM_001267550.2(TTN):c.92780T>A (p.Ile30927Lys)

gnomAD frequency: 0.00001  dbSNP: rs531432790

Total submissions: 10

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine	RCV000156609	SCV000206329	uncertain significance	not specified	2014-06-27	criteria provided, single submitter	clinical testing	The Ile28359Lys variant in TTN has not been previously reported in individuals w ith cardiomyopathy or in large population studies. Computational prediction too ls and conservation analysis do not provide strong support for or against an imp act to the protein. In summary, the clinical significance of the Ile28359Lys var iant is uncertain.
GeneDx	RCV000156609	SCV000237770	likely benign	not specified	2017-11-16	criteria provided, single submitter	clinical testing	This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Invitae	RCV001086729	SCV000765414	benign	Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J	2024-01-31	criteria provided, single submitter	clinical testing
CeGaT Center for Human Genetics Tuebingen	RCV000643727	SCV001152655	uncertain significance	not provided	2018-04-01	criteria provided, single submitter	clinical testing
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario	RCV001171250	SCV001333954	benign	Cardiomyopathy	2018-04-12	criteria provided, single submitter	clinical testing
Genetics and Genomics Program, Sidra Medicine	RCV001293089	SCV001434072	uncertain significance	Primary dilated cardiomyopathy		criteria provided, single submitter	research
Ambry Genetics	RCV002362832	SCV002664784	likely benign	Cardiovascular phenotype	2019-09-11	criteria provided, single submitter	clinical testing	This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Clinical Genetics, Academic Medical Center	RCV000156609	SCV001922264	benign	not specified		no assertion criteria provided	clinical testing
Genome Diagnostics Laboratory, University Medical Center Utrecht	RCV000156609	SCV001928362	benign	not specified		no assertion criteria provided	clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center	RCV000156609	SCV001971771	benign	not specified		no assertion criteria provided	clinical testing